Mark Turco, MD

Mark TurcoChief Innovation Officer, Penn Health-Tech. Chief Innovation and Corporate Outreach Officer, Penn Center for Innovation.

Dr. Mark A. Turco, an experienced scientific and business development executive with industry expertise, who joined the University of Pennsylvania as Chief Innovation and Corporate Outreach Officer for the Penn Center for Innovation January 2017. A Penn graduate and Philadelphia native, Dr. Turco is a resource for the University of Pennsylvania innovators leading University and PCI outreach and relationship-building efforts with both internal and external partners as part of the University’s efforts to expand innovation and translational opportunities regionally, nationally and globally. He is responsible for helping to successfully translate into external commercial partnerships Penn based technologies and inventions and develop industry academic partnerships to further the Universities efforts around innovation.

Most recently, Dr. Turco served as the Vice President and Chief Medical Officer of the vascular franchises of Medtronic Inc. In this role, he provided strategy to inform complex decisions that encompass patient needs, clinical trial design, regulatory considerations, and evolving healthcare systems and value-based models—both domestically and internationally. He also evaluated opportunities for growth and investment through medical, business, payers, providers, and regulators lenses.

Dr. Turco received his medical degree and internal medicine training at the George Washington University in Washington, D.C. He practiced as an interventional cardiologist in the Washington, D.C. area for 16 years, serving as Director of the Cardiovascular Research Center at Washington Adventist Hospital and maintaining an active patient care practice. As a practicing cardiologist, Dr. Turco also played a role in the development of several medical devices currently being utilized in the field of cardio-vascular medicine.

After leaving Washington Adventist Hospital, Dr. Turco served as the Chief Medical Officer for Covidien, Vascular Therapies prior to joining Medtronic at the time of Medtronic acquiring Covidien.

Given Dr. Turco’s medical device background he has been part of the leadership team helping in the development of Penn’s new Center for medical devices, Penn Health-Tech.